{"entity":{"id":"nct06868849","kind":"trial","name":"A Study of JMT203 in Patients With Cancer Cachexia","aka":[],"tldr":"A phase 1/2 trial of JMT203 Injection in non-small-cell lung cancer, pancreatic ductal adenocarcinoma and colorectal cancer, run by Shanghai JMT-Bio Inc., now recruiting.","summary":"A Study of JMT203 in Patients With Cancer Cachexia is a phase 1/2 interventional study registered as NCT06868849 by Shanghai JMT-Bio Inc., with 307 participants planned, started 2024-05-15 and due to reach its primary completion in 2027-08-14. Interventions recorded: JMT203 Injection.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06868849","url":"https://clinicaltrials.gov/study/NCT06868849"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc","pancreatic","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["cspc"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06868849","phase":"1/2","setting":"A Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of JMT203 in Patients With Cancer Cachexia","sponsor":"Shanghai JMT-Bio Inc.","enrolled":307,"outcomes":[]},"route":"/trials/nct06868849/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"company":[{"id":"cspc","kind":"company","name":"CSPC Pharmaceutical Group","route":"/companies/cspc/"}],"drug":[{"id":"jmt203","kind":"drug","name":"JMT203","route":"/drugs/jmt203/"}]}}